United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$6.4Mraised across 2 rounds since 2023, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 1 on the team.
On the board, as filediChristine S. GallagherJackson S. StreeterJeffrey S. ArnoldJeffrey S. Ives
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Astrocyte Pharmaceuticals's investors include National Institutes of Health, Kaitai Capital, DeepWork Capital, Dreavent Capital and Life Science Angels, and 6 more on record.
Astrocyte Pharmaceuticals has raised $6.4M across 2 rounds since 2023.
Astrocyte Pharmaceuticals's most recent round was a Grant of $400K in Aug 2026.
Astrocyte Pharmaceuticals's largest round on record is $6.0M (Series B), in Aug 2023, led by Dreavent Capital.
Astrocyte Pharmaceuticals's first round on record, in Aug 2023, was backed by Dreavent Capital, National Institutes of Health and Kaitai Capital and 8 others.
Astrocyte Pharmaceuticals's latest named round is a Grant, in Aug 2026.
Astrocyte Pharmaceuticals is based in the United States.
Dreavent Capital led the Series B in 2023.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
